Skip to main content

Peer Review reports

From: A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome

Original Submission
5 Apr 2019 Submitted Original manuscript
29 Dec 2019 Reviewed Reviewer Report - Daisy Kosa
13 Jan 2020 Reviewed Reviewer Report - Jonathan Adachi
21 Feb 2020 Author responded Author comments - Kimberly Legault
Resubmission - Version 2
21 Feb 2020 Submitted Manuscript version 2
Publishing
3 Apr 2020 Editorially accepted
25 Apr 2020 Article published 10.1186/s40814-020-00594-1

You can find further information about peer review here.

Back to article page